Glioblastoma is a brain neoplasm with limited 5-year survival rates. Developments of new treatment regimens that improve patient survival in patients with glioblastoma are needed. It is likely that a number of existing drugs used in other conditions have potential anticancer effects that offer significant survival benefit to glioblastoma patients. Identification of such drugs could provide a novel treatment paradigm.
Keywords: antidepressants; antiepileptic drugs; antihypertensive; beta-blockers; glioblastoma; statins.
© 2015 The British Pharmacological Society.